Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Coyle

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Addiction (Abingdon, England)|October 31, 2012
Fetal assessment before and after dosing with buprenorphine or methadoneAmy L Salisbury, Mara G Coyle, Kevin E O'Grady, et al.
The American Journal on Addictions|June 22, 2013
Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurementHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Addiction (Abingdon, England)|October 31, 2012
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive reviewHendrée E Jones, Sarah H Heil, Andjela Baewert, et al.
Addiction (Abingdon, England)|October 31, 2012
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medicationLaura F McNicholas, Amber M Holbrook, Kevin E O'Grady, et al.
The American Journal of Drug and Alcohol Abuse|February 26, 2010
Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samplesH E Jones, S H Heil, K E O'Grady, et al.
The New England Journal of Medicine|December 15, 2010
Neonatal abstinence syndrome after methadone or buprenorphine exposureHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
European Addiction Research|February 18, 2010
Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatmentA S Unger, P R Martin, K Kaltenbach, et al.
Journal of Substance Abuse Treatment|February 6, 2008
Treatment of opioid-dependent pregnant women: clinical and research issuesHendree E Jones, Peter R Martin, Sarah H Heil, et al.
Addiction (Abingdon, England)|October 31, 2012
Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learnedHendrée E Jones, Gabriele Fischer, Sarah H Heil, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|February 2, 2012
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?Hendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Addiction (Abingdon, England)|October 31, 2012
Fetal assessment before and after dosing with buprenorphine or methadoneAmy L Salisbury, Mara G Coyle, Kevin E O'Grady, et al.
The American Journal on Addictions|June 22, 2013
Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurementHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Addiction (Abingdon, England)|October 31, 2012
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive reviewHendrée E Jones, Sarah H Heil, Andjela Baewert, et al.
Addiction (Abingdon, England)|October 31, 2012
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medicationLaura F McNicholas, Amber M Holbrook, Kevin E O'Grady, et al.
The American Journal of Drug and Alcohol Abuse|February 26, 2010
Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samplesH E Jones, S H Heil, K E O'Grady, et al.
The New England Journal of Medicine|December 15, 2010
Neonatal abstinence syndrome after methadone or buprenorphine exposureHendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
European Addiction Research|February 18, 2010
Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatmentA S Unger, P R Martin, K Kaltenbach, et al.
Journal of Substance Abuse Treatment|February 6, 2008
Treatment of opioid-dependent pregnant women: clinical and research issuesHendree E Jones, Peter R Martin, Sarah H Heil, et al.
Addiction (Abingdon, England)|October 31, 2012
Maternal Opioid Treatment: Human Experimental Research (MOTHER)--approach, issues and lessons learnedHendrée E Jones, Gabriele Fischer, Sarah H Heil, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|February 2, 2012
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?Hendrée E Jones, Karol Kaltenbach, Sarah H Heil, et al.
Pageof 6